nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—multiple sclerosis	0.346	1	CiPCiCtD
Gemcitabine—RRM1—multiple sclerosis	0.184	1	CbGaD
Gemcitabine—Azacitidine—Cladribine—multiple sclerosis	0.0723	0.512	CrCrCtD
Gemcitabine—Decitabine—Cladribine—multiple sclerosis	0.0689	0.488	CrCrCtD
Gemcitabine—POLE—Cladribine—multiple sclerosis	0.062	0.241	CbGbCtD
Gemcitabine—RRM2—Cladribine—multiple sclerosis	0.0412	0.16	CbGbCtD
Gemcitabine—RRM1—Cladribine—multiple sclerosis	0.0412	0.16	CbGbCtD
Gemcitabine—POLA1—Cladribine—multiple sclerosis	0.0356	0.139	CbGbCtD
Gemcitabine—SLC28A3—Cladribine—multiple sclerosis	0.0356	0.139	CbGbCtD
Gemcitabine—DCK—Cladribine—multiple sclerosis	0.0219	0.0853	CbGbCtD
Gemcitabine—TYMS—Methotrexate—multiple sclerosis	0.00667	0.0259	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—multiple sclerosis	0.0055	0.0214	CbGbCtD
Gemcitabine—ABCB1—Methylprednisolone—multiple sclerosis	0.00169	0.00656	CbGbCtD
Gemcitabine—ABCB1—Mitoxantrone—multiple sclerosis	0.00123	0.00478	CbGbCtD
Gemcitabine—ABCB1—Betamethasone—multiple sclerosis	0.0011	0.00426	CbGbCtD
Gemcitabine—ABCB1—Prednisolone—multiple sclerosis	0.00108	0.00421	CbGbCtD
Gemcitabine—ABCB1—Prednisone—multiple sclerosis	0.00102	0.00397	CbGbCtD
Gemcitabine—ABCB1—Dexamethasone—multiple sclerosis	0.000637	0.00248	CbGbCtD
Gemcitabine—POLD1—Nucleotide Metabolism—RRM1—multiple sclerosis	0.000581	0.0306	CbGpPWpGaD
Gemcitabine—ABCB1—Methotrexate—multiple sclerosis	0.000512	0.00199	CbGbCtD
Gemcitabine—CMPK1—brainstem—multiple sclerosis	0.000492	0.0484	CbGeAlD
Gemcitabine—CMPK1—Nucleotide metabolism—RRM1—multiple sclerosis	0.00049	0.0258	CbGpPWpGaD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000418	0.022	CbGpPWpGaD
Gemcitabine—POLA1—Nucleotide Metabolism—RRM1—multiple sclerosis	0.0004	0.0211	CbGpPWpGaD
Gemcitabine—POLA1—retina—multiple sclerosis	0.000384	0.0377	CbGeAlD
Gemcitabine—RRM2—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000376	0.0198	CbGpPWpGaD
Gemcitabine—CMPK1—midbrain—multiple sclerosis	0.000314	0.0308	CbGeAlD
Gemcitabine—CMPK1—spinal cord—multiple sclerosis	0.000306	0.0301	CbGeAlD
Gemcitabine—RRM1—retina—multiple sclerosis	0.000304	0.0299	CbGeAlD
Gemcitabine—POLD1—cerebellum—multiple sclerosis	0.000304	0.0299	CbGeAlD
Gemcitabine—CDA—Nucleotide metabolism—RRM1—multiple sclerosis	0.000303	0.0159	CbGpPWpGaD
Gemcitabine—CMPK1—nervous system—multiple sclerosis	0.000258	0.0254	CbGeAlD
Gemcitabine—SLC29A2—cerebellum—multiple sclerosis	0.000255	0.0251	CbGeAlD
Gemcitabine—CMPK1—central nervous system—multiple sclerosis	0.000248	0.0244	CbGeAlD
Gemcitabine—POLD1—brain—multiple sclerosis	0.000247	0.0243	CbGeAlD
Gemcitabine—TYMS—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000246	0.013	CbGpPWpGaD
Gemcitabine—CMPK1—cerebellum—multiple sclerosis	0.000243	0.0239	CbGeAlD
Gemcitabine—POLE—nervous system—multiple sclerosis	0.000242	0.0238	CbGeAlD
Gemcitabine—DCK—retina—multiple sclerosis	0.000236	0.0232	CbGeAlD
Gemcitabine—POLE—central nervous system—multiple sclerosis	0.000233	0.0229	CbGeAlD
Gemcitabine—POLE—cerebellum—multiple sclerosis	0.000227	0.0224	CbGeAlD
Gemcitabine—RRM1—medulla oblongata—multiple sclerosis	0.00022	0.0216	CbGeAlD
Gemcitabine—SLC29A2—brain—multiple sclerosis	0.000207	0.0204	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000201	0.0106	CbGpPWpGaD
Gemcitabine—RRM1—midbrain—multiple sclerosis	0.000201	0.0198	CbGeAlD
Gemcitabine—RRM2—E2F transcription factor network—RRM1—multiple sclerosis	0.000199	0.0105	CbGpPWpGaD
Gemcitabine—RRM2—nervous system—multiple sclerosis	0.000199	0.0196	CbGeAlD
Gemcitabine—CMPK1—brain—multiple sclerosis	0.000197	0.0194	CbGeAlD
Gemcitabine—RRM1—spinal cord—multiple sclerosis	0.000196	0.0193	CbGeAlD
Gemcitabine—POLA1—cerebellum—multiple sclerosis	0.000196	0.0193	CbGeAlD
Gemcitabine—RRM2—central nervous system—multiple sclerosis	0.000192	0.0188	CbGeAlD
Gemcitabine—RRM2—Nucleotide metabolism—RRM1—multiple sclerosis	0.000189	0.00995	CbGpPWpGaD
Gemcitabine—POLE—brain—multiple sclerosis	0.000185	0.0182	CbGeAlD
Gemcitabine—TYMS—midbrain—multiple sclerosis	0.000182	0.0179	CbGeAlD
Gemcitabine—SLC28A1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000179	0.00941	CbGpPWpGaD
Gemcitabine—DCK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000177	0.0093	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000173	0.00912	CbGpPWpGaD
Gemcitabine—DCK—medulla oblongata—multiple sclerosis	0.000171	0.0168	CbGeAlD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000166	0.00875	CbGpPWpGaD
Gemcitabine—RRM1—nervous system—multiple sclerosis	0.000165	0.0163	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000164	0.00864	CbGpPWpGaD
Gemcitabine—ABCC10—medulla oblongata—multiple sclerosis	0.000163	0.016	CbGeAlD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000162	0.00852	CbGpPWpGaD
Gemcitabine—POLA1—brain—multiple sclerosis	0.000159	0.0157	CbGeAlD
Gemcitabine—RRM1—central nervous system—multiple sclerosis	0.000159	0.0156	CbGeAlD
Gemcitabine—DCK—midbrain—multiple sclerosis	0.000156	0.0154	CbGeAlD
Gemcitabine—RRM1—cerebellum—multiple sclerosis	0.000156	0.0153	CbGeAlD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000152	0.00803	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000152	0.00803	CbGpPWpGaD
Gemcitabine—DCK—spinal cord—multiple sclerosis	0.000152	0.015	CbGeAlD
Gemcitabine—RRM2—brain—multiple sclerosis	0.000152	0.015	CbGeAlD
Gemcitabine—TYMS—nervous system—multiple sclerosis	0.00015	0.0147	CbGeAlD
Gemcitabine—ABCC10—midbrain—multiple sclerosis	0.000149	0.0146	CbGeAlD
Gemcitabine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000146	0.00767	CbGpPWpGaD
Gemcitabine—ABCC10—spinal cord—multiple sclerosis	0.000145	0.0143	CbGeAlD
Gemcitabine—TYMS—central nervous system—multiple sclerosis	0.000144	0.0142	CbGeAlD
Gemcitabine—TYMS—cerebellum—multiple sclerosis	0.000141	0.0139	CbGeAlD
Gemcitabine—POLA1—E2F transcription factor network—RRM1—multiple sclerosis	0.000136	0.00718	CbGpPWpGaD
Gemcitabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000135	0.00713	CbGpPWpGaD
Gemcitabine—SLC29A1—nervous system—multiple sclerosis	0.000134	0.0132	CbGeAlD
Gemcitabine—TYMS—E2F transcription factor network—RRM1—multiple sclerosis	0.000131	0.00687	CbGpPWpGaD
Gemcitabine—SLC29A1—central nervous system—multiple sclerosis	0.000129	0.0127	CbGeAlD
Gemcitabine—DCK—nervous system—multiple sclerosis	0.000128	0.0126	CbGeAlD
Gemcitabine—SLC29A1—cerebellum—multiple sclerosis	0.000127	0.0124	CbGeAlD
Gemcitabine—RRM1—brain—multiple sclerosis	0.000126	0.0124	CbGeAlD
Gemcitabine—POLD1—Azacitidine—Cladribine—multiple sclerosis	0.000126	0.112	CbGdCrCtD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000124	0.00655	CbGpPWpGaD
Gemcitabine—TYMS—Nucleotide metabolism—RRM1—multiple sclerosis	0.000124	0.00652	CbGpPWpGaD
Gemcitabine—DCK—central nervous system—multiple sclerosis	0.000124	0.0122	CbGeAlD
Gemcitabine—DCK—cerebellum—multiple sclerosis	0.000121	0.0119	CbGeAlD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000118	0.00624	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000116	0.00608	CbGpPWpGaD
Gemcitabine—ABCC10—cerebellum—multiple sclerosis	0.000115	0.0113	CbGeAlD
Gemcitabine—TYMS—brain—multiple sclerosis	0.000115	0.0113	CbGeAlD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000114	0.00599	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000113	0.00597	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000107	0.00561	CbGpPWpGaD
Gemcitabine—SLC29A1—brain—multiple sclerosis	0.000103	0.0101	CbGeAlD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000102	0.00538	CbGpPWpGaD
Gemcitabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000101	0.00532	CbGpPWpGaD
Gemcitabine—RRM1—Azacitidine—Cladribine—multiple sclerosis	0.0001	0.0884	CbGdCrCtD
Gemcitabine—DCK—brain—multiple sclerosis	9.82e-05	0.00965	CbGeAlD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	9.8e-05	0.00516	CbGpPWpGaD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	9.8e-05	0.00516	CbGpPWpGaD
Gemcitabine—ABCC10—brain—multiple sclerosis	9.35e-05	0.00919	CbGeAlD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.69e-05	0.00457	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.62e-05	0.00454	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SRM—multiple sclerosis	8.34e-05	0.00439	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.33e-05	0.00439	CbGpPWpGaD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.08e-05	0.00425	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.75e-05	0.00408	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.75e-05	0.00408	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.29e-05	0.00384	CbGpPWpGaD
Gemcitabine—ABCB1—retina—multiple sclerosis	6.51e-05	0.00639	CbGeAlD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.32e-05	0.00333	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.31e-05	0.00332	CbGpPWpGaD
Gemcitabine—RRM2—Azacitidine—Cladribine—multiple sclerosis	6.29e-05	0.0555	CbGdCrCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.14e-05	0.00323	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.13e-05	0.00323	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.05e-05	0.00318	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.02e-05	0.00317	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP27B1—multiple sclerosis	5.87e-05	0.00309	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP24A1—multiple sclerosis	5.87e-05	0.00309	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.87e-05	0.00309	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.78e-05	0.00304	CbGpPWpGaD
Gemcitabine—POLD1—Danazol—Prednisone—multiple sclerosis	5.59e-05	0.0494	CbGdCrCtD
Gemcitabine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	5.58e-05	0.00294	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.52e-05	0.00291	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.41e-05	0.00285	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GPC5—multiple sclerosis	5.37e-05	0.00283	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—SRM—multiple sclerosis	5.15e-05	0.00271	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.99e-05	0.00263	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.93e-05	0.0026	CbGpPWpGaD
Gemcitabine—ABCB1—medulla oblongata—multiple sclerosis	4.7e-05	0.00462	CbGeAlD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.64e-05	0.00244	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—RRM1—multiple sclerosis	4.45e-05	0.00234	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.41e-05	0.00232	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.38e-05	0.00231	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.36e-05	0.0023	CbGpPWpGaD
Gemcitabine—ABCB1—midbrain—multiple sclerosis	4.3e-05	0.00422	CbGeAlD
Gemcitabine—ABCB1—Allograft Rejection—C4A—multiple sclerosis	4.24e-05	0.00223	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.22e-05	0.00222	CbGpPWpGaD
Gemcitabine—ABCB1—spinal cord—multiple sclerosis	4.19e-05	0.00412	CbGeAlD
Gemcitabine—RRM1—E2F transcription factor network—MYC—multiple sclerosis	4.15e-05	0.00219	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.1e-05	0.00216	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SRM—multiple sclerosis	3.9e-05	0.00206	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.86e-05	0.00203	CbGpPWpGaD
Gemcitabine—SLC28A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.84e-05	0.00202	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP24A1—multiple sclerosis	3.63e-05	0.00191	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP27B1—multiple sclerosis	3.63e-05	0.00191	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	3.61e-05	0.0019	CbGpPWpGaD
Gemcitabine—ABCB1—nervous system—multiple sclerosis	3.53e-05	0.00347	CbGeAlD
Gemcitabine—POLE—G1 to S cell cycle control—MYC—multiple sclerosis	3.47e-05	0.00183	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.46e-05	0.00182	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.46e-05	0.00182	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	3.46e-05	0.00182	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	3.46e-05	0.00182	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—MYC—multiple sclerosis	3.42e-05	0.0018	CbGpPWpGaD
Gemcitabine—ABCB1—central nervous system—multiple sclerosis	3.4e-05	0.00334	CbGeAlD
Gemcitabine—ABCB1—cerebellum—multiple sclerosis	3.32e-05	0.00327	CbGeAlD
Gemcitabine—CDA—Metabolism—GPC5—multiple sclerosis	3.32e-05	0.00175	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.31e-05	0.00174	CbGpPWpGaD
Gemcitabine—Angiopathy—Dexamethasone—multiple sclerosis	3.26e-05	0.000776	CcSEcCtD
Gemcitabine—Decreased appetite—Mitoxantrone—multiple sclerosis	3.24e-05	0.000772	CcSEcCtD
Gemcitabine—Hypertension—Prednisolone—multiple sclerosis	3.23e-05	0.000771	CcSEcCtD
Gemcitabine—RRM2—Metabolism—SRM—multiple sclerosis	3.21e-05	0.00169	CbGpPWpGaD
Gemcitabine—Fatigue—Mitoxantrone—multiple sclerosis	3.21e-05	0.000765	CcSEcCtD
Gemcitabine—Arrhythmia—Betamethasone—multiple sclerosis	3.21e-05	0.000764	CcSEcCtD
Gemcitabine—Arrhythmia—Dexamethasone—multiple sclerosis	3.21e-05	0.000764	CcSEcCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.2e-05	0.00169	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SRM—multiple sclerosis	3.2e-05	0.00168	CbGpPWpGaD
Gemcitabine—Ill-defined disorder—Triamcinolone—multiple sclerosis	3.19e-05	0.000762	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	3.19e-05	0.00076	CcSEcCtD
Gemcitabine—Constipation—Mitoxantrone—multiple sclerosis	3.18e-05	0.000759	CcSEcCtD
Gemcitabine—Pain—Mitoxantrone—multiple sclerosis	3.18e-05	0.000759	CcSEcCtD
Gemcitabine—Alopecia—Dexamethasone—multiple sclerosis	3.17e-05	0.000756	CcSEcCtD
Gemcitabine—Alopecia—Betamethasone—multiple sclerosis	3.17e-05	0.000756	CcSEcCtD
Gemcitabine—Diarrhoea—Azathioprine—multiple sclerosis	3.15e-05	0.000751	CcSEcCtD
Gemcitabine—Discomfort—Prednisolone—multiple sclerosis	3.15e-05	0.000751	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	3.15e-05	0.00166	CbGpPWpGaD
Gemcitabine—Haemoglobin—Prednisone—multiple sclerosis	3.14e-05	0.000749	CcSEcCtD
Gemcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.13e-05	0.00165	CbGpPWpGaD
Gemcitabine—Haemorrhage—Prednisone—multiple sclerosis	3.13e-05	0.000745	CcSEcCtD
Gemcitabine—Erythema—Dexamethasone—multiple sclerosis	3.12e-05	0.000745	CcSEcCtD
Gemcitabine—Erythema—Betamethasone—multiple sclerosis	3.12e-05	0.000745	CcSEcCtD
Gemcitabine—Malaise—Triamcinolone—multiple sclerosis	3.1e-05	0.00074	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—multiple sclerosis	3.1e-05	0.000739	CcSEcCtD
Gemcitabine—Malaise—Methylprednisolone—multiple sclerosis	3.1e-05	0.000739	CcSEcCtD
Gemcitabine—Connective tissue disorder—Prednisone—multiple sclerosis	3.07e-05	0.000732	CcSEcCtD
Gemcitabine—Feeling abnormal—Mitoxantrone—multiple sclerosis	3.07e-05	0.000732	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.06e-05	0.00161	CbGpPWpGaD
Gemcitabine—Oedema—Prednisolone—multiple sclerosis	3.06e-05	0.000728	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisolone—multiple sclerosis	3.06e-05	0.000728	CcSEcCtD
Gemcitabine—Neutropenia—Methotrexate—multiple sclerosis	3.05e-05	0.000727	CcSEcCtD
Gemcitabine—Cough—Triamcinolone—multiple sclerosis	3e-05	0.000716	CcSEcCtD
Gemcitabine—DCK—Metabolism—SRM—multiple sclerosis	3e-05	0.00158	CbGpPWpGaD
Gemcitabine—Hypertension—Triamcinolone—multiple sclerosis	2.97e-05	0.000709	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.97e-05	0.00156	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	2.97e-05	0.00156	CbGpPWpGaD
Gemcitabine—Hypertension—Methylprednisolone—multiple sclerosis	2.97e-05	0.000707	CcSEcCtD
Gemcitabine—Hyperhidrosis—Prednisolone—multiple sclerosis	2.95e-05	0.000704	CcSEcCtD
Gemcitabine—Body temperature increased—Mitoxantrone—multiple sclerosis	2.94e-05	0.000702	CcSEcCtD
Gemcitabine—Myalgia—Triamcinolone—multiple sclerosis	2.93e-05	0.000699	CcSEcCtD
Gemcitabine—Vomiting—Azathioprine—multiple sclerosis	2.93e-05	0.000698	CcSEcCtD
Gemcitabine—Pneumonia—Methotrexate—multiple sclerosis	2.93e-05	0.000698	CcSEcCtD
Gemcitabine—Arthralgia—Methylprednisolone—multiple sclerosis	2.92e-05	0.000697	CcSEcCtD
Gemcitabine—Myalgia—Methylprednisolone—multiple sclerosis	2.92e-05	0.000697	CcSEcCtD
Gemcitabine—SLC28A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.91e-05	0.00153	CbGpPWpGaD
Gemcitabine—Rash—Azathioprine—multiple sclerosis	2.9e-05	0.000693	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	2.9e-05	0.000692	CcSEcCtD
Gemcitabine—Dermatitis—Azathioprine—multiple sclerosis	2.9e-05	0.000692	CcSEcCtD
Gemcitabine—Ill-defined disorder—Dexamethasone—multiple sclerosis	2.9e-05	0.000691	CcSEcCtD
Gemcitabine—Ill-defined disorder—Betamethasone—multiple sclerosis	2.9e-05	0.000691	CcSEcCtD
Gemcitabine—Discomfort—Triamcinolone—multiple sclerosis	2.9e-05	0.00069	CcSEcCtD
Gemcitabine—Discomfort—Methylprednisolone—multiple sclerosis	2.89e-05	0.000689	CcSEcCtD
Gemcitabine—Headache—Azathioprine—multiple sclerosis	2.89e-05	0.000688	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	2.88e-05	0.000688	CcSEcCtD
Gemcitabine—Renal failure—Methotrexate—multiple sclerosis	2.86e-05	0.000682	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.85e-05	0.0015	CbGpPWpGaD
Gemcitabine—Stomatitis—Methotrexate—multiple sclerosis	2.84e-05	0.000676	CcSEcCtD
Gemcitabine—Angiopathy—Prednisone—multiple sclerosis	2.84e-05	0.000676	CcSEcCtD
Gemcitabine—Immune system disorder—Prednisone—multiple sclerosis	2.82e-05	0.000673	CcSEcCtD
Gemcitabine—Malaise—Betamethasone—multiple sclerosis	2.82e-05	0.000672	CcSEcCtD
Gemcitabine—Malaise—Dexamethasone—multiple sclerosis	2.82e-05	0.000672	CcSEcCtD
Gemcitabine—Anaphylactic shock—Triamcinolone—multiple sclerosis	2.81e-05	0.00067	CcSEcCtD
Gemcitabine—Oedema—Triamcinolone—multiple sclerosis	2.81e-05	0.00067	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	2.8e-05	0.000668	CcSEcCtD
Gemcitabine—Arrhythmia—Prednisone—multiple sclerosis	2.79e-05	0.000666	CcSEcCtD
Gemcitabine—Infection—Triamcinolone—multiple sclerosis	2.79e-05	0.000666	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—multiple sclerosis	2.79e-05	0.000665	CcSEcCtD
Gemcitabine—Infection—Methylprednisolone—multiple sclerosis	2.79e-05	0.000664	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.78e-05	0.00146	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.78e-05	0.00146	CbGpPWpGaD
Gemcitabine—Haematuria—Methotrexate—multiple sclerosis	2.77e-05	0.000661	CcSEcCtD
Gemcitabine—Insomnia—Prednisolone—multiple sclerosis	2.76e-05	0.000659	CcSEcCtD
Gemcitabine—Alopecia—Prednisone—multiple sclerosis	2.76e-05	0.000658	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—multiple sclerosis	2.75e-05	0.000656	CcSEcCtD
Gemcitabine—CDA—Metabolism—RRM1—multiple sclerosis	2.75e-05	0.00145	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP27B1—multiple sclerosis	2.75e-05	0.00145	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP24A1—multiple sclerosis	2.75e-05	0.00145	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Methylprednisolone—multiple sclerosis	2.75e-05	0.000655	CcSEcCtD
Gemcitabine—Paraesthesia—Prednisolone—multiple sclerosis	2.74e-05	0.000654	CcSEcCtD
Gemcitabine—Nausea—Azathioprine—multiple sclerosis	2.74e-05	0.000652	CcSEcCtD
Gemcitabine—Skin disorder—Methylprednisolone—multiple sclerosis	2.72e-05	0.000649	CcSEcCtD
Gemcitabine—Erythema—Prednisone—multiple sclerosis	2.72e-05	0.000649	CcSEcCtD
Gemcitabine—Hyperhidrosis—Triamcinolone—multiple sclerosis	2.72e-05	0.000648	CcSEcCtD
Gemcitabine—Agranulocytosis—Methotrexate—multiple sclerosis	2.72e-05	0.000647	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	2.71e-05	0.000646	CcSEcCtD
Gemcitabine—ABCB1—brain—multiple sclerosis	2.7e-05	0.00265	CbGeAlD
Gemcitabine—Hypertension—Dexamethasone—multiple sclerosis	2.7e-05	0.000643	CcSEcCtD
Gemcitabine—Hypertension—Betamethasone—multiple sclerosis	2.7e-05	0.000643	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	2.69e-05	0.00142	CbGpPWpGaD
Gemcitabine—TYMS—Azacitidine—Cladribine—multiple sclerosis	2.68e-05	0.0237	CbGdCrCtD
Gemcitabine—Asthenia—Mitoxantrone—multiple sclerosis	2.67e-05	0.000637	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.66e-05	0.0014	CbGpPWpGaD
Gemcitabine—Myalgia—Betamethasone—multiple sclerosis	2.66e-05	0.000634	CcSEcCtD
Gemcitabine—Myalgia—Dexamethasone—multiple sclerosis	2.66e-05	0.000634	CcSEcCtD
Gemcitabine—Discomfort—Dexamethasone—multiple sclerosis	2.63e-05	0.000626	CcSEcCtD
Gemcitabine—Discomfort—Betamethasone—multiple sclerosis	2.63e-05	0.000626	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—multiple sclerosis	2.63e-05	0.000626	CcSEcCtD
Gemcitabine—Hypotension—Methylprednisolone—multiple sclerosis	2.62e-05	0.000625	CcSEcCtD
Gemcitabine—Pain—Prednisolone—multiple sclerosis	2.61e-05	0.000623	CcSEcCtD
Gemcitabine—Haemorrhage—Methotrexate—multiple sclerosis	2.61e-05	0.000623	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—multiple sclerosis	2.59e-05	0.000618	CcSEcCtD
Gemcitabine—Urinary tract disorder—Methotrexate—multiple sclerosis	2.58e-05	0.000615	CcSEcCtD
Gemcitabine—Urethral disorder—Methotrexate—multiple sclerosis	2.56e-05	0.00061	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.56e-05	0.00061	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—BCHE—multiple sclerosis	2.56e-05	0.00135	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.55e-05	0.000609	CcSEcCtD
Gemcitabine—Oedema—Betamethasone—multiple sclerosis	2.55e-05	0.000608	CcSEcCtD
Gemcitabine—Oedema—Dexamethasone—multiple sclerosis	2.55e-05	0.000608	CcSEcCtD
Gemcitabine—Anaphylactic shock—Dexamethasone—multiple sclerosis	2.55e-05	0.000608	CcSEcCtD
Gemcitabine—Anaphylactic shock—Betamethasone—multiple sclerosis	2.55e-05	0.000608	CcSEcCtD
Gemcitabine—Diarrhoea—Mitoxantrone—multiple sclerosis	2.55e-05	0.000608	CcSEcCtD
Gemcitabine—Insomnia—Triamcinolone—multiple sclerosis	2.54e-05	0.000606	CcSEcCtD
Gemcitabine—Insomnia—Methylprednisolone—multiple sclerosis	2.54e-05	0.000605	CcSEcCtD
Gemcitabine—Infection—Dexamethasone—multiple sclerosis	2.53e-05	0.000604	CcSEcCtD
Gemcitabine—Infection—Betamethasone—multiple sclerosis	2.53e-05	0.000604	CcSEcCtD
Gemcitabine—Ill-defined disorder—Prednisone—multiple sclerosis	2.52e-05	0.000602	CcSEcCtD
Gemcitabine—Paraesthesia—Triamcinolone—multiple sclerosis	2.52e-05	0.000602	CcSEcCtD
Gemcitabine—Feeling abnormal—Prednisolone—multiple sclerosis	2.52e-05	0.0006	CcSEcCtD
Gemcitabine—Paraesthesia—Methylprednisolone—multiple sclerosis	2.52e-05	0.0006	CcSEcCtD
Gemcitabine—RRM1—Metabolism—GPC5—multiple sclerosis	2.52e-05	0.00132	CbGpPWpGaD
Gemcitabine—Anaemia—Prednisone—multiple sclerosis	2.51e-05	0.000599	CcSEcCtD
Gemcitabine—Dyspnoea—Triamcinolone—multiple sclerosis	2.51e-05	0.000597	CcSEcCtD
Gemcitabine—Nervous system disorder—Dexamethasone—multiple sclerosis	2.5e-05	0.000596	CcSEcCtD
Gemcitabine—Nervous system disorder—Betamethasone—multiple sclerosis	2.5e-05	0.000596	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dexamethasone—multiple sclerosis	2.5e-05	0.000595	CcSEcCtD
Gemcitabine—Thrombocytopenia—Betamethasone—multiple sclerosis	2.5e-05	0.000595	CcSEcCtD
Gemcitabine—RRM2—G1/S Transition—MYC—multiple sclerosis	2.48e-05	0.00131	CbGpPWpGaD
Gemcitabine—Erythema multiforme—Methotrexate—multiple sclerosis	2.47e-05	0.000589	CcSEcCtD
Gemcitabine—Hyperhidrosis—Betamethasone—multiple sclerosis	2.46e-05	0.000588	CcSEcCtD
Gemcitabine—Hyperhidrosis—Dexamethasone—multiple sclerosis	2.46e-05	0.000588	CcSEcCtD
Gemcitabine—Malaise—Prednisone—multiple sclerosis	2.45e-05	0.000585	CcSEcCtD
Gemcitabine—Anorexia—Betamethasone—multiple sclerosis	2.43e-05	0.000579	CcSEcCtD
Gemcitabine—Anorexia—Dexamethasone—multiple sclerosis	2.43e-05	0.000579	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—multiple sclerosis	2.42e-05	0.000578	CcSEcCtD
Gemcitabine—Fatigue—Triamcinolone—multiple sclerosis	2.42e-05	0.000578	CcSEcCtD
Gemcitabine—Fatigue—Methylprednisolone—multiple sclerosis	2.42e-05	0.000576	CcSEcCtD
Gemcitabine—Pain—Triamcinolone—multiple sclerosis	2.4e-05	0.000573	CcSEcCtD
Gemcitabine—Hypotension—Dexamethasone—multiple sclerosis	2.38e-05	0.000568	CcSEcCtD
Gemcitabine—Hypotension—Betamethasone—multiple sclerosis	2.38e-05	0.000568	CcSEcCtD
Gemcitabine—POLE—G1/S Transition—MYC—multiple sclerosis	2.38e-05	0.00125	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.38e-05	0.00125	CbGpPWpGaD
Gemcitabine—Angiopathy—Methotrexate—multiple sclerosis	2.37e-05	0.000565	CcSEcCtD
Gemcitabine—Vomiting—Mitoxantrone—multiple sclerosis	2.37e-05	0.000565	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—multiple sclerosis	2.36e-05	0.000562	CcSEcCtD
Gemcitabine—Mediastinal disorder—Methotrexate—multiple sclerosis	2.35e-05	0.000561	CcSEcCtD
Gemcitabine—Hypertension—Prednisone—multiple sclerosis	2.35e-05	0.00056	CcSEcCtD
Gemcitabine—Rash—Mitoxantrone—multiple sclerosis	2.35e-05	0.00056	CcSEcCtD
Gemcitabine—Dermatitis—Mitoxantrone—multiple sclerosis	2.35e-05	0.000559	CcSEcCtD
Gemcitabine—Chills—Methotrexate—multiple sclerosis	2.34e-05	0.000559	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—MYC—multiple sclerosis	2.34e-05	0.00123	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	2.34e-05	0.00123	CbGpPWpGaD
Gemcitabine—Headache—Mitoxantrone—multiple sclerosis	2.33e-05	0.000556	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.32e-05	0.000554	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.32e-05	0.000554	CcSEcCtD
Gemcitabine—Arthralgia—Prednisone—multiple sclerosis	2.32e-05	0.000552	CcSEcCtD
Gemcitabine—Myalgia—Prednisone—multiple sclerosis	2.32e-05	0.000552	CcSEcCtD
Gemcitabine—Feeling abnormal—Triamcinolone—multiple sclerosis	2.32e-05	0.000552	CcSEcCtD
Gemcitabine—Feeling abnormal—Methylprednisolone—multiple sclerosis	2.31e-05	0.000551	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—multiple sclerosis	2.31e-05	0.00055	CcSEcCtD
Gemcitabine—Insomnia—Betamethasone—multiple sclerosis	2.31e-05	0.00055	CcSEcCtD
Gemcitabine—Insomnia—Dexamethasone—multiple sclerosis	2.31e-05	0.00055	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	2.3e-05	0.000548	CcSEcCtD
Gemcitabine—Paraesthesia—Dexamethasone—multiple sclerosis	2.29e-05	0.000546	CcSEcCtD
Gemcitabine—Paraesthesia—Betamethasone—multiple sclerosis	2.29e-05	0.000546	CcSEcCtD
Gemcitabine—Discomfort—Prednisone—multiple sclerosis	2.29e-05	0.000546	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.28e-05	0.0012	CbGpPWpGaD
Gemcitabine—Erythema—Methotrexate—multiple sclerosis	2.27e-05	0.000542	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CD28—multiple sclerosis	2.27e-05	0.0012	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP27B1—multiple sclerosis	2.26e-05	0.00119	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP24A1—multiple sclerosis	2.26e-05	0.00119	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP24A1—multiple sclerosis	2.25e-05	0.00119	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP27B1—multiple sclerosis	2.25e-05	0.00119	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—MYC—multiple sclerosis	2.24e-05	0.00118	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—MYC—multiple sclerosis	2.24e-05	0.00118	CbGpPWpGaD
Gemcitabine—Body temperature increased—Triamcinolone—multiple sclerosis	2.22e-05	0.00053	CcSEcCtD
Gemcitabine—Anaphylactic shock—Prednisone—multiple sclerosis	2.22e-05	0.000529	CcSEcCtD
Gemcitabine—Oedema—Prednisone—multiple sclerosis	2.22e-05	0.000529	CcSEcCtD
Gemcitabine—Decreased appetite—Dexamethasone—multiple sclerosis	2.22e-05	0.000528	CcSEcCtD
Gemcitabine—Decreased appetite—Betamethasone—multiple sclerosis	2.22e-05	0.000528	CcSEcCtD
Gemcitabine—Nausea—Mitoxantrone—multiple sclerosis	2.21e-05	0.000527	CcSEcCtD
Gemcitabine—Infection—Prednisone—multiple sclerosis	2.21e-05	0.000526	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	2.2e-05	0.000525	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	2.2e-05	0.000525	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—multiple sclerosis	2.2e-05	0.000524	CcSEcCtD
Gemcitabine—Fatigue—Betamethasone—multiple sclerosis	2.2e-05	0.000524	CcSEcCtD
Gemcitabine—Fatigue—Dexamethasone—multiple sclerosis	2.2e-05	0.000524	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—FAS—multiple sclerosis	2.19e-05	0.00115	CbGpPWpGaD
Gemcitabine—Pain—Betamethasone—multiple sclerosis	2.18e-05	0.00052	CcSEcCtD
Gemcitabine—Pain—Dexamethasone—multiple sclerosis	2.18e-05	0.00052	CcSEcCtD
Gemcitabine—Nervous system disorder—Prednisone—multiple sclerosis	2.18e-05	0.000519	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	2.17e-05	0.00114	CbGpPWpGaD
Gemcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.17e-05	0.00114	CbGpPWpGaD
Gemcitabine—POLE—S Phase—MYC—multiple sclerosis	2.16e-05	0.00114	CbGpPWpGaD
Gemcitabine—Skin disorder—Prednisone—multiple sclerosis	2.16e-05	0.000514	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	2.15e-05	0.00113	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Prednisone—multiple sclerosis	2.15e-05	0.000512	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	2.12e-05	0.0188	CbGdCrCtD
Gemcitabine—DCK—Metabolism—CYP24A1—multiple sclerosis	2.12e-05	0.00111	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP27B1—multiple sclerosis	2.12e-05	0.00111	CbGpPWpGaD
Gemcitabine—Anorexia—Prednisone—multiple sclerosis	2.12e-05	0.000505	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—multiple sclerosis	2.11e-05	0.000503	CcSEcCtD
Gemcitabine—TYMS—Metabolism—SRM—multiple sclerosis	2.11e-05	0.00111	CbGpPWpGaD
Gemcitabine—Anaemia—Methotrexate—multiple sclerosis	2.1e-05	0.000501	CcSEcCtD
Gemcitabine—Feeling abnormal—Dexamethasone—multiple sclerosis	2.1e-05	0.000501	CcSEcCtD
Gemcitabine—Feeling abnormal—Betamethasone—multiple sclerosis	2.1e-05	0.000501	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—MYC—multiple sclerosis	2.09e-05	0.0011	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Betamethasone—multiple sclerosis	2.09e-05	0.0185	CbGdCrCtD
Gemcitabine—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	2.09e-05	0.0185	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—CD40—multiple sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GPC5—multiple sclerosis	2.07e-05	0.00109	CbGpPWpGaD
Gemcitabine—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	2.06e-05	0.0182	CbGdCrCtD
Gemcitabine—POLD1—Metabolism—GPC5—multiple sclerosis	2.06e-05	0.00108	CbGpPWpGaD
Gemcitabine—Malaise—Methotrexate—multiple sclerosis	2.05e-05	0.000489	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	2.04e-05	0.018	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	2.04e-05	0.00108	CbGpPWpGaD
Gemcitabine—Leukopenia—Methotrexate—multiple sclerosis	2.04e-05	0.000485	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.03e-05	0.00107	CbGpPWpGaD
Gemcitabine—DCK—Diflorasone—Betamethasone—multiple sclerosis	2.03e-05	0.0179	CbGdCrCtD
Gemcitabine—DCK—Diflorasone—Dexamethasone—multiple sclerosis	2.03e-05	0.0179	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.02e-05	0.000482	CcSEcCtD
Gemcitabine—Asthenia—Triamcinolone—multiple sclerosis	2.02e-05	0.000481	CcSEcCtD
Gemcitabine—Body temperature increased—Dexamethasone—multiple sclerosis	2.02e-05	0.00048	CcSEcCtD
Gemcitabine—Body temperature increased—Betamethasone—multiple sclerosis	2.02e-05	0.00048	CcSEcCtD
Gemcitabine—Asthenia—Methylprednisolone—multiple sclerosis	2.01e-05	0.00048	CcSEcCtD
Gemcitabine—Insomnia—Prednisone—multiple sclerosis	2.01e-05	0.000479	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—MYC—multiple sclerosis	2.01e-05	0.00106	CbGpPWpGaD
Gemcitabine—Paraesthesia—Prednisone—multiple sclerosis	1.99e-05	0.000475	CcSEcCtD
Gemcitabine—Pruritus—Triamcinolone—multiple sclerosis	1.99e-05	0.000474	CcSEcCtD
Gemcitabine—Cough—Methotrexate—multiple sclerosis	1.98e-05	0.000473	CcSEcCtD
Gemcitabine—Pruritus—Methylprednisolone—multiple sclerosis	1.98e-05	0.000473	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Triamcinolone—multiple sclerosis	1.98e-05	0.0175	CbGdCrCtD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.95e-05	0.00103	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.95e-05	0.00103	CbGpPWpGaD
Gemcitabine—DCK—Desoximetasone—Prednisone—multiple sclerosis	1.94e-05	0.0171	CbGdCrCtD
Gemcitabine—DCK—Metabolism—GPC5—multiple sclerosis	1.94e-05	0.00102	CbGpPWpGaD
Gemcitabine—Myalgia—Methotrexate—multiple sclerosis	1.94e-05	0.000461	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—multiple sclerosis	1.94e-05	0.000461	CcSEcCtD
Gemcitabine—Arthralgia—Methotrexate—multiple sclerosis	1.94e-05	0.000461	CcSEcCtD
Gemcitabine—Decreased appetite—Prednisone—multiple sclerosis	1.93e-05	0.00046	CcSEcCtD
Gemcitabine—Rash—Prednisolone—multiple sclerosis	1.93e-05	0.000459	CcSEcCtD
Gemcitabine—Dermatitis—Prednisolone—multiple sclerosis	1.92e-05	0.000459	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.92e-05	0.00101	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	1.92e-05	0.000458	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.92e-05	0.00101	CbGpPWpGaD
Gemcitabine—Diarrhoea—Methylprednisolone—multiple sclerosis	1.92e-05	0.000457	CcSEcCtD
Gemcitabine—Fatigue—Prednisone—multiple sclerosis	1.91e-05	0.000456	CcSEcCtD
Gemcitabine—Headache—Prednisolone—multiple sclerosis	1.91e-05	0.000456	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—multiple sclerosis	1.91e-05	0.000456	CcSEcCtD
Gemcitabine—Constipation—Prednisone—multiple sclerosis	1.9e-05	0.000453	CcSEcCtD
Gemcitabine—DCK—Desoximetasone—Prednisolone—multiple sclerosis	1.89e-05	0.0167	CbGdCrCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.88e-05	0.000991	CbGpPWpGaD
Gemcitabine—DCK—Diflorasone—Prednisone—multiple sclerosis	1.88e-05	0.0166	CbGdCrCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	1.87e-05	0.000983	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Methotrexate—multiple sclerosis	1.86e-05	0.000442	CcSEcCtD
Gemcitabine—Infection—Methotrexate—multiple sclerosis	1.84e-05	0.000439	CcSEcCtD
Gemcitabine—DCK—Diflorasone—Prednisolone—multiple sclerosis	1.84e-05	0.0162	CbGdCrCtD
Gemcitabine—Feeling abnormal—Prednisone—multiple sclerosis	1.83e-05	0.000436	CcSEcCtD
Gemcitabine—Asthenia—Dexamethasone—multiple sclerosis	1.83e-05	0.000436	CcSEcCtD
Gemcitabine—Asthenia—Betamethasone—multiple sclerosis	1.83e-05	0.000436	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—multiple sclerosis	1.82e-05	0.000434	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—multiple sclerosis	1.82e-05	0.000433	CcSEcCtD
Gemcitabine—Nausea—Prednisolone—multiple sclerosis	1.81e-05	0.000433	CcSEcCtD
Gemcitabine—Pruritus—Betamethasone—multiple sclerosis	1.8e-05	0.00043	CcSEcCtD
Gemcitabine—Pruritus—Dexamethasone—multiple sclerosis	1.8e-05	0.00043	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—multiple sclerosis	1.8e-05	0.00043	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	1.8e-05	0.000947	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Methotrexate—multiple sclerosis	1.79e-05	0.000428	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.79e-05	0.000943	CbGpPWpGaD
Gemcitabine—Vomiting—Triamcinolone—multiple sclerosis	1.79e-05	0.000426	CcSEcCtD
Gemcitabine—Vomiting—Methylprednisolone—multiple sclerosis	1.78e-05	0.000425	CcSEcCtD
Gemcitabine—Rash—Triamcinolone—multiple sclerosis	1.77e-05	0.000422	CcSEcCtD
Gemcitabine—Dermatitis—Triamcinolone—multiple sclerosis	1.77e-05	0.000422	CcSEcCtD
Gemcitabine—Anorexia—Methotrexate—multiple sclerosis	1.77e-05	0.000422	CcSEcCtD
Gemcitabine—Rash—Methylprednisolone—multiple sclerosis	1.77e-05	0.000421	CcSEcCtD
Gemcitabine—Dermatitis—Methylprednisolone—multiple sclerosis	1.77e-05	0.000421	CcSEcCtD
Gemcitabine—Headache—Triamcinolone—multiple sclerosis	1.76e-05	0.00042	CcSEcCtD
Gemcitabine—Headache—Methylprednisolone—multiple sclerosis	1.76e-05	0.000419	CcSEcCtD
Gemcitabine—Body temperature increased—Prednisone—multiple sclerosis	1.76e-05	0.000418	CcSEcCtD
Gemcitabine—Diarrhoea—Dexamethasone—multiple sclerosis	1.74e-05	0.000416	CcSEcCtD
Gemcitabine—Diarrhoea—Betamethasone—multiple sclerosis	1.74e-05	0.000416	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—multiple sclerosis	1.73e-05	0.000413	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	1.72e-05	0.0152	CbGdCrCtD
Gemcitabine—RRM2—Metabolism—RRM1—multiple sclerosis	1.72e-05	0.000904	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RRM1—multiple sclerosis	1.71e-05	0.000898	CbGpPWpGaD
Gemcitabine—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	1.7e-05	0.015	CbGdCrCtD
Gemcitabine—POLA1—G1/S Transition—MYC—multiple sclerosis	1.7e-05	0.000893	CbGpPWpGaD
Gemcitabine—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	1.7e-05	0.015	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	1.7e-05	0.015	CbGdCrCtD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.69e-05	0.000403	CcSEcCtD
Gemcitabine—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	1.68e-05	0.0149	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	1.68e-05	0.000885	CbGpPWpGaD
Gemcitabine—Insomnia—Methotrexate—multiple sclerosis	1.68e-05	0.0004	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Betamethasone—multiple sclerosis	1.67e-05	0.0148	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	1.67e-05	0.0148	CbGdCrCtD
Gemcitabine—Nausea—Triamcinolone—multiple sclerosis	1.67e-05	0.000398	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—multiple sclerosis	1.67e-05	0.000397	CcSEcCtD
Gemcitabine—Nausea—Methylprednisolone—multiple sclerosis	1.67e-05	0.000397	CcSEcCtD
Gemcitabine—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	1.66e-05	0.0146	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	1.66e-05	0.0146	CbGdCrCtD
Gemcitabine—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	1.66e-05	0.0146	CbGdCrCtD
Gemcitabine—Dyspnoea—Methotrexate—multiple sclerosis	1.65e-05	0.000394	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—multiple sclerosis	1.65e-05	0.000393	CcSEcCtD
Gemcitabine—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	1.64e-05	0.0145	CbGdCrCtD
Gemcitabine—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	1.64e-05	0.0145	CbGdCrCtD
Gemcitabine—TYMS—G1/S Transition—MYC—multiple sclerosis	1.63e-05	0.000856	CbGpPWpGaD
Gemcitabine—Vomiting—Dexamethasone—multiple sclerosis	1.62e-05	0.000386	CcSEcCtD
Gemcitabine—Vomiting—Betamethasone—multiple sclerosis	1.62e-05	0.000386	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	1.62e-05	0.000853	CbGpPWpGaD
Gemcitabine—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	1.62e-05	0.0143	CbGdCrCtD
Gemcitabine—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	1.62e-05	0.0143	CbGdCrCtD
Gemcitabine—Decreased appetite—Methotrexate—multiple sclerosis	1.61e-05	0.000385	CcSEcCtD
Gemcitabine—Rash—Betamethasone—multiple sclerosis	1.61e-05	0.000383	CcSEcCtD
Gemcitabine—Rash—Dexamethasone—multiple sclerosis	1.61e-05	0.000383	CcSEcCtD
Gemcitabine—Dermatitis—Dexamethasone—multiple sclerosis	1.61e-05	0.000383	CcSEcCtD
Gemcitabine—Dermatitis—Betamethasone—multiple sclerosis	1.61e-05	0.000383	CcSEcCtD
Gemcitabine—DCK—Metabolism—RRM1—multiple sclerosis	1.6e-05	0.000845	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.6e-05	0.000382	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—multiple sclerosis	1.6e-05	0.000381	CcSEcCtD
Gemcitabine—Headache—Dexamethasone—multiple sclerosis	1.6e-05	0.000381	CcSEcCtD
Gemcitabine—Headache—Betamethasone—multiple sclerosis	1.6e-05	0.000381	CcSEcCtD
Gemcitabine—Asthenia—Prednisone—multiple sclerosis	1.59e-05	0.00038	CcSEcCtD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.59e-05	0.000837	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	1.59e-05	0.000836	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	1.59e-05	0.000836	CbGpPWpGaD
Gemcitabine—Pain—Methotrexate—multiple sclerosis	1.59e-05	0.000378	CcSEcCtD
Gemcitabine—CDA—Metabolism—BCHE—multiple sclerosis	1.58e-05	0.000832	CbGpPWpGaD
Gemcitabine—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	1.58e-05	0.0139	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	1.57e-05	0.0139	CbGdCrCtD
Gemcitabine—Pruritus—Prednisone—multiple sclerosis	1.57e-05	0.000374	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisone—multiple sclerosis	1.55e-05	0.0137	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	1.55e-05	0.0137	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	1.54e-05	0.000813	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—MYC—multiple sclerosis	1.54e-05	0.000811	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—APOE—multiple sclerosis	1.54e-05	0.00081	CbGpPWpGaD
Gemcitabine—TYMS—Triamcinolone—Prednisone—multiple sclerosis	1.54e-05	0.0136	CbGdCrCtD
Gemcitabine—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	1.54e-05	0.0136	CbGdCrCtD
Gemcitabine—Feeling abnormal—Methotrexate—multiple sclerosis	1.53e-05	0.000365	CcSEcCtD
Gemcitabine—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	1.53e-05	0.0135	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Betamethasone—multiple sclerosis	1.53e-05	0.0135	CbGdCrCtD
Gemcitabine—Diarrhoea—Prednisone—multiple sclerosis	1.52e-05	0.000362	CcSEcCtD
Gemcitabine—TYMS—Flunisolide—Prednisolone—multiple sclerosis	1.52e-05	0.0134	CbGdCrCtD
Gemcitabine—Nausea—Betamethasone—multiple sclerosis	1.51e-05	0.000361	CcSEcCtD
Gemcitabine—Nausea—Dexamethasone—multiple sclerosis	1.51e-05	0.000361	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	1.51e-05	0.000795	CbGpPWpGaD
Gemcitabine—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	1.5e-05	0.0133	CbGdCrCtD
Gemcitabine—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	1.49e-05	0.0132	CbGdCrCtD
Gemcitabine—TYMS—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.000781	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.000781	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.48e-05	0.000778	CbGpPWpGaD
Gemcitabine—Body temperature increased—Methotrexate—multiple sclerosis	1.47e-05	0.00035	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.43e-05	0.000753	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.42e-05	0.00075	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Prednisone—multiple sclerosis	1.42e-05	0.0125	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.42e-05	0.000745	CbGpPWpGaD
Gemcitabine—Vomiting—Prednisone—multiple sclerosis	1.41e-05	0.000337	CcSEcCtD
Gemcitabine—Rash—Prednisone—multiple sclerosis	1.4e-05	0.000334	CcSEcCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.4e-05	0.000737	CbGpPWpGaD
Gemcitabine—Dermatitis—Prednisone—multiple sclerosis	1.4e-05	0.000333	CcSEcCtD
Gemcitabine—Headache—Prednisone—multiple sclerosis	1.39e-05	0.000332	CcSEcCtD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.39e-05	0.000731	CbGpPWpGaD
Gemcitabine—TYMS—Diflorasone—Prednisolone—multiple sclerosis	1.38e-05	0.0122	CbGdCrCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.37e-05	0.000721	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	1.36e-05	0.012	CbGdCrCtD
Gemcitabine—TYMS—Metabolism—GPC5—multiple sclerosis	1.36e-05	0.000715	CbGpPWpGaD
Gemcitabine—TYMS—Budesonide—Dexamethasone—multiple sclerosis	1.34e-05	0.0118	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Betamethasone—multiple sclerosis	1.34e-05	0.0118	CbGdCrCtD
Gemcitabine—Asthenia—Methotrexate—multiple sclerosis	1.33e-05	0.000317	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—POMC—multiple sclerosis	1.32e-05	0.000696	CbGpPWpGaD
Gemcitabine—Nausea—Prednisone—multiple sclerosis	1.32e-05	0.000314	CcSEcCtD
Gemcitabine—Pruritus—Methotrexate—multiple sclerosis	1.31e-05	0.000313	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Triamcinolone—multiple sclerosis	1.31e-05	0.0116	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.28e-05	0.000673	CbGpPWpGaD
Gemcitabine—Diarrhoea—Methotrexate—multiple sclerosis	1.27e-05	0.000303	CcSEcCtD
Gemcitabine—TYMS—Budesonide—Prednisone—multiple sclerosis	1.24e-05	0.011	CbGdCrCtD
Gemcitabine—TYMS—Budesonide—Prednisolone—multiple sclerosis	1.21e-05	0.0107	CbGdCrCtD
Gemcitabine—CMPK1—Metabolism—ALB—multiple sclerosis	1.2e-05	0.000634	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.00063	CbGpPWpGaD
Gemcitabine—TYMS—Danazol—Prednisone—multiple sclerosis	1.19e-05	0.0105	CbGdCrCtD
Gemcitabine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.18e-05	0.000622	CbGpPWpGaD
Gemcitabine—Vomiting—Methotrexate—multiple sclerosis	1.18e-05	0.000281	CcSEcCtD
Gemcitabine—Rash—Methotrexate—multiple sclerosis	1.17e-05	0.000279	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—multiple sclerosis	1.17e-05	0.000279	CcSEcCtD
Gemcitabine—Headache—Methotrexate—multiple sclerosis	1.16e-05	0.000277	CcSEcCtD
Gemcitabine—TYMS—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000592	CbGpPWpGaD
Gemcitabine—Nausea—Methotrexate—multiple sclerosis	1.1e-05	0.000263	CcSEcCtD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.1e-05	0.00058	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.08e-05	0.00057	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.08e-05	0.000569	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.06e-05	0.000558	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.05e-05	0.000554	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.04e-05	0.000546	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.04e-05	0.000545	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.02e-05	0.000538	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.02e-05	0.000535	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.01e-05	0.000531	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—BCHE—multiple sclerosis	9.86e-06	0.000519	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—BCHE—multiple sclerosis	9.8e-06	0.000516	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.67e-06	0.000509	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—MAPK1—multiple sclerosis	9.63e-06	0.000507	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	9.51e-06	0.000501	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOE—multiple sclerosis	9.5e-06	0.0005	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	9.34e-06	0.000492	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—BCHE—multiple sclerosis	9.21e-06	0.000485	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	8.33e-06	0.000439	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	8.3e-06	0.000437	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.21e-06	0.000432	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—POMC—multiple sclerosis	8.16e-06	0.00043	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.97e-06	0.00042	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.67e-06	0.000404	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.62e-06	0.000401	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	7.5e-06	0.000395	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	7.49e-06	0.000394	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	7.45e-06	0.000393	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—multiple sclerosis	7.44e-06	0.000392	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.36e-06	0.000388	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOE—multiple sclerosis	7.2e-06	0.000379	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	7.2e-06	0.000379	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.03e-06	0.00037	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—MAPK1—multiple sclerosis	6.86e-06	0.000361	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—multiple sclerosis	6.86e-06	0.000361	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—multiple sclerosis	6.81e-06	0.000359	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MAPK1—multiple sclerosis	6.71e-06	0.000353	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MAPK1—multiple sclerosis	6.67e-06	0.000351	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—multiple sclerosis	6.58e-06	0.000346	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SRM—multiple sclerosis	6.5e-06	0.000342	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	6.47e-06	0.000341	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—BCHE—multiple sclerosis	6.46e-06	0.00034	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MAPK1—multiple sclerosis	6.44e-06	0.000339	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.3e-06	0.000332	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—POMC—multiple sclerosis	6.19e-06	0.000326	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	6.04e-06	0.000318	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOE—multiple sclerosis	5.93e-06	0.000312	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOE—multiple sclerosis	5.89e-06	0.00031	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—multiple sclerosis	5.64e-06	0.000297	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.57e-06	0.000293	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—multiple sclerosis	5.54e-06	0.000292	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.24e-06	0.000276	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	5.13e-06	0.00027	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—POMC—multiple sclerosis	5.1e-06	0.000268	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—POMC—multiple sclerosis	5.06e-06	0.000267	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.02e-06	0.000265	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	4.91e-06	0.000259	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—POMC—multiple sclerosis	4.76e-06	0.000251	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—multiple sclerosis	4.69e-06	0.000247	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—multiple sclerosis	4.65e-06	0.000245	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—multiple sclerosis	4.62e-06	0.000243	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MAPK1—multiple sclerosis	4.59e-06	0.000242	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.58e-06	0.000241	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.58e-06	0.000241	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—multiple sclerosis	4.49e-06	0.000237	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MAPK1—multiple sclerosis	4.39e-06	0.000231	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—multiple sclerosis	4.34e-06	0.000229	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GPC5—multiple sclerosis	4.19e-06	0.000221	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOE—multiple sclerosis	3.89e-06	0.000205	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RRM1—multiple sclerosis	3.47e-06	0.000183	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—POMC—multiple sclerosis	3.34e-06	0.000176	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.2e-06	0.000169	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.19e-06	0.000168	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.13e-06	0.000165	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—multiple sclerosis	3.04e-06	0.00016	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.98e-06	0.000157	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.01e-06	0.000106	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—BCHE—multiple sclerosis	1.99e-06	0.000105	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—multiple sclerosis	1.2e-06	6.31e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—POMC—multiple sclerosis	1.03e-06	5.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—multiple sclerosis	9.39e-07	4.95e-05	CbGpPWpGaD
